ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

Clinical trial NCT05081245 · COMPLETED

Trial details

NCT number: NCT05081245
Sponsor: MapLight Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2022-09-13
Primary completion: 2026-03-10
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.